These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12898457)

  • 21. Reverse cholesterol transport and future pharmacological approaches to the treatment of atherosclerosis.
    Krause BR; Auerbach BJ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):375-81. PubMed ID: 11575708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse cholesterol transport with acute exercise.
    Campaigne BN; Fontaine RN; Park MS; Rymaszewski ZJ
    Med Sci Sports Exerc; 1993 Dec; 25(12):1346-51. PubMed ID: 8107540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quercetin improves macrophage reverse cholesterol transport in apolipoprotein E-deficient mice fed a high-fat diet.
    Cui Y; Hou P; Li F; Liu Q; Qin S; Zhou G; Xu X; Si Y; Guo S
    Lipids Health Dis; 2017 Jan; 16(1):9. PubMed ID: 28088205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The associations among thoracic aortic atherosclerosis, coronary atherosclerosis and the function of high density lipoprotein.
    Takao M; Zhang B; Fan P; Nomoto J; Saku K
    Atherosclerosis; 2001 Dec; 159(2):407-16. PubMed ID: 11730821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid parameters in patients with acute coronary syndromes versus stable coronary artery disease.
    Vonbank A; Saely CH; Rein P; Drexel H
    Eur J Clin Invest; 2015 Oct; 45(10):1092-7. PubMed ID: 26255620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular regulation of HDL metabolism and function: implications for novel therapies.
    Rader DJ
    J Clin Invest; 2006 Dec; 116(12):3090-100. PubMed ID: 17143322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-density lipoprotein synthesis and metabolism (Review).
    Zhou L; Li C; Gao L; Wang A
    Mol Med Rep; 2015 Sep; 12(3):4015-4021. PubMed ID: 26082200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reverse cholesterol transport processes and their role in artherosclerosis regression].
    Chachaj A; Drozdz K; Szuba A
    Postepy Biochem; 2008; 54(3):301-7. PubMed ID: 19112829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P2Y13 receptor is critical for reverse cholesterol transport.
    Fabre AC; Malaval C; Ben Addi A; Verdier C; Pons V; Serhan N; Lichtenstein L; Combes G; Huby T; Briand F; Collet X; Nijstad N; Tietge UJ; Robaye B; Perret B; Boeynaems JM; Martinez LO
    Hepatology; 2010 Oct; 52(4):1477-83. PubMed ID: 20830789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is so special about apolipoprotein AI in reverse cholesterol transport?
    Curtiss LK; Valenta DT; Hime NJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):12-9. PubMed ID: 16269660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease.
    Boyer M; Lévesque V; Poirier P; Marette A; Mathieu P; Després JP; Larose É; Arsenault BJ
    J Clin Lipidol; 2016; 10(6):1353-1361. PubMed ID: 27919352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular cholesterol flux studies: methodological considerations.
    Rothblat GH; de la Llera-Moya M; Favari E; Yancey PG; Kellner-Weibel G
    Atherosclerosis; 2002 Jul; 163(1):1-8. PubMed ID: 12048116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL-cholesterol in coronary artery disease risk: function or structure?
    Pérez-Méndez Ó; Pacheco HG; Martínez-Sánchez C; Franco M
    Clin Chim Acta; 2014 Feb; 429():111-22. PubMed ID: 24333390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approaches.
    Strang AC; Hovingh GK; Stroes ES; Kastelein JJ
    Am J Cardiol; 2009 Nov; 104(10 Suppl):22E-31E. PubMed ID: 19895941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol efflux and reverse cholesterol transport.
    Favari E; Chroni A; Tietge UJ; Zanotti I; Escolà-Gil JC; Bernini F
    Handb Exp Pharmacol; 2015; 224():181-206. PubMed ID: 25522988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-enzymatic glycosylation of apolipoprotein A-I and its functional consequences.
    Fiévet C; Igau B; Bresson R; Drouin P; Fruchart JC
    Diabete Metab; 1995 Apr; 21(2):95-8. PubMed ID: 7621978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical fitness and reverse cholesterol transport.
    Olchawa B; Kingwell BA; Hoang A; Schneider L; Miyazaki O; Nestel P; Sviridov D
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1087-91. PubMed ID: 15072992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural studies of discoidal lipoprotein A-I.
    Koppaka V
    Cell Mol Life Sci; 2001 Jun; 58(7):885-93. PubMed ID: 11497237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.